Personal information

No personal information available

Activities

Employment (1)

Boehringer Ingelheim International GmbH: Ingelheim, Rheinland-Pfalz, DE

2008-04-01 to present | Head of Global Development Cardiovascular (Medicine)
Employment
Source: Self-asserted source
Martina Brueckmann

Education and qualifications (3)

University of Heidelberg-Mannheim: Mannheim, Baden-Württemberg, DE

Professorship, Internal Medicine & Cardiology
Qualification
Source: Self-asserted source
Martina Brueckmann

Heidelberg University: Heidelberg, DE

Medical Doctor, Internal Medicine & Cardiology
Qualification
Source: Self-asserted source
Martina Brueckmann

Goethe University Frankfurt: Frankfurt am Main, Hessen, DE

Medical Degree, Medical Doctor
Qualification
Source: Self-asserted source
Martina Brueckmann

Professional activities (1)

European Society of Cardiology: Sophia Antipolis, PACA, FR

Source: Self-asserted source
Martina Brueckmann

Works (11)

Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™‐1 and ‐2)

Obesity
2025-01 | Journal article
Contributors: Sean Wharton; Carel W. le Roux; Mikhail N. Kosiborod; Elke Platz; Martina Brueckmann; Ania M. Jastreboff; Samina Ajaz Hussain; Sue D. Pedersen; Luiza Borowska; Anna Unseld et al.
Source: check_circle
Crossref

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure

Circulation
2023-09-26 | Journal article
Contributors: Milton Packer; Javed Butler; Cordula Zeller; Stuart J. Pocock; Martina Brueckmann; João Pedro Ferreira; Gerasimos Filippatos; Muhammad Shariq Usman; Faiez Zannad; Stefan D. Anker
Source: check_circle
Crossref

Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial

European Heart Journal
2023-02-01 | Journal article
Contributors: Michael Böhm; Stefan Anker; Felix Mahfoud; Lucas Lauder; Gerasimos Filippatos; João Pedro Ferreira; Stuart J Pocock; Martina Brueckmann; Ilias Saloustros; Elke Schüler et al.
Source: check_circle
Crossref

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

Circulation
2022-10-04 | Journal article
Contributors: Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; João Pedro Ferreira; Martina Brueckmann; Edimar Bocchi; Michael Böhm; Vijay K. Chopra; Nadia Giannetti; Tomoko Iwata et al.
Source: check_circle
Crossref

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

Circulation
2022-08-30 | Journal article
Contributors: Gerasimos Filippatos; Javed Butler; Dimitrios Farmakis; Faiez Zannad; Anne Pernille Ofstad; João Pedro Ferreira; Jennifer B. Green; Julio Rosenstock; Sven Schnaidt; Martina Brueckmann et al.
Source: check_circle
Crossref

Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial

Journal of the American Heart Association
2022-06-07 | Journal article
Contributors: Victor J. Del Brutto; Han‐Christoph Diener; J. Donald Easton; Christopher B. Granger; Lisa Cronin; Eva Kleine; Claudia Grauer; Martina Brueckmann; Kazunori Toyoda; Peter D. Schellinger et al.
Source: check_circle
Crossref

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

European Heart Journal
2022-02-03 | Journal article
Contributors: Javed Butler; Milton Packer; Gerasimos Filippatos; Joao Pedro Ferreira; Cordula Zeller; Janet Schnee; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Stefan D Anker
Source: check_circle
Crossref

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Circulation
2022-01-18 | Journal article
Contributors: Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; Martina Brueckmann; Michael Böhm; Vijay K. Chopra; João Pedro Ferreira; James L. Januzzi; Sanjay Kaul; Ileana L. Piña et al.
Source: check_circle
Crossref

Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial

Circulation
2021-11-30 | Journal article
Contributors: Maria Cecilia Bahit; Ralph L. Sacco; J. Donald Easton; Juliane Meyerhoff; Lisa Cronin; Eva Kleine; Claudia Grauer; Martina Brueckmann; Hans-Christoph Diener; Renato D. Lopes et al.
Source: check_circle
Crossref

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

European Heart Journal
2021-11-14 | Journal article
Contributors: Stuart J Pocock; João Pedro Ferreira; John Gregson; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Nicholas D Gollop; Tomoko Iwata; Martina Brueckmann; James L Januzzi, Jr et al.
Source: check_circle
Crossref

Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials

Circulation
2021-10-12 | Journal article
Contributors: Stefan D. Anker; Piotr Ponikowski; Christoph Wanner; Egon Pfarr; Sibylle Hauske; Barbara Peil; Afshin Salsali; Ivana Ritter; Audrey Koitka-Weber; Martina Brueckmann et al.
Source: check_circle
Crossref